Found 146 matching trials
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection PHASE3 This study is a randomized, open-label, multicentric, phase III trial condu...
Show More Location
Centre Hospitalier Universitaire
Learn More & Join Trial
Ruxolitinib in Estrogen Receptor Positive Breast Cancer PHASE2 This is a Phase II investigator-Initiated trial of the Investigational Drug...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer PHASE3 The purpose of this open-label, multicenter, phase IIIb, single-arm study i...
Show More Location
Central Alabama Research
Learn More & Join Trial
Exemestane in Post-Menopausal Women With NSCLC PHASE2 This is a phase II therapeutic study of adding exemestane therapy in post-m...
Show More Location
Mayo Clinic Health System
Learn More & Join Trial
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor PHASE2 This study aimed at evaluating the safety and efficacy of everolimus plus e...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer PHASE1 The purpose of this study is to determine the safety, tolerability and phar...
Show More Location
ATTN-Research Pharmacist
Learn More & Join Trial
Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer PHASE2 The purpose of this study is to evaluate the safety and efficacy of entinos...
Show More Location
California Cancer Care
Learn More & Join Trial
Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT PHASE3 To examine whether the occurrence of oral mucositis can be reduced by denta...
Show More Location
Tokai University, School of Medicine
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial
Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients PHASE2 A Randomized, Open label, Parallel-group, Multi-center study. Eligible pati...
Show More Location
National Cancer Institute, Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial